中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
14期
74-75
,共2页
杨晓东%鲍文华%张智勇%阎红娥%孙云晖%马雪梅
楊曉東%鮑文華%張智勇%閻紅娥%孫雲暉%馬雪梅
양효동%포문화%장지용%염홍아%손운휘%마설매
荧光支气管镜%肺癌%诊断
熒光支氣管鏡%肺癌%診斷
형광지기관경%폐암%진단
Autofluorescence bronchoscopy%Lung cancer%Diagnosis
目的:探讨荧光支气管镜在肺癌早期诊断中临床意义.方法:选取符合入选标准的患者160例,随机分为白光电子支气管镜组(WLB组)和自发性荧光支气管镜组(AFB组),检查获取病理和留取冲洗液,统计肺癌诊断数据,对两组确诊肺癌患者检出情况及两组中镜下异常表现进行分析.结果:AFB组中肺癌检出率60.42%,WLB组中肺癌检出率45.31%,AFB组肺癌检出率明显高于WLB组(P<0.01).AFB组镜下异常表现阳性率90.50%,WLB组阳性率64.30%,AFB组镜下异常表现阳性率明显高于WLB组(P<0.01).结论:AFB检查确诊肺癌明显优于WLB尤其对肺癌早期诊断.
目的:探討熒光支氣管鏡在肺癌早期診斷中臨床意義.方法:選取符閤入選標準的患者160例,隨機分為白光電子支氣管鏡組(WLB組)和自髮性熒光支氣管鏡組(AFB組),檢查穫取病理和留取遲洗液,統計肺癌診斷數據,對兩組確診肺癌患者檢齣情況及兩組中鏡下異常錶現進行分析.結果:AFB組中肺癌檢齣率60.42%,WLB組中肺癌檢齣率45.31%,AFB組肺癌檢齣率明顯高于WLB組(P<0.01).AFB組鏡下異常錶現暘性率90.50%,WLB組暘性率64.30%,AFB組鏡下異常錶現暘性率明顯高于WLB組(P<0.01).結論:AFB檢查確診肺癌明顯優于WLB尤其對肺癌早期診斷.
목적:탐토형광지기관경재폐암조기진단중림상의의.방법:선취부합입선표준적환자160례,수궤분위백광전자지기관경조(WLB조)화자발성형광지기관경조(AFB조),검사획취병리화류취충세액,통계폐암진단수거,대량조학진폐암환자검출정황급량조중경하이상표현진행분석.결과:AFB조중폐암검출솔60.42%,WLB조중폐암검출솔45.31%,AFB조폐암검출솔명현고우WLB조(P<0.01).AFB조경하이상표현양성솔90.50%,WLB조양성솔64.30%,AFB조경하이상표현양성솔명현고우WLB조(P<0.01).결론:AFB검사학진폐암명현우우WLB우기대폐암조기진단.
Objective:To investigate the clinical significance of autofluorescence bronchoscopy(AFB)in the early diagnosis of lung cancer. Method:160 patients were randomly divided into white light bronchoscopy group(WLB group)and autofluorescence bronchoscopy group(AFB group), and all suspicious findings were recorded for biopsy specimens and bronchoalveolar lavage fluid,and all statistical data of lung cancer patients and endoscopic abnormal detections were analyzed in two groups.Result:The diagnostic rate of lung cancer was 60.42%in AFB group,the diagnostic rate of lung cancer was 45.31%in WLB group,the diagnostic rate of AFB group was significantly higher than WLB group(P<0.01).The AFB group,the positive rate of endoscopic abnormal detection was 90.50%,the WLB group,the positive rate of 64.30%,the positive rate of AFB group was significantly higher than the WLB group(P<0.01).Conclusion:AFB is significantly superior to WLB especially for early diagnosis of lung cancer.